Skip to content

Effect of Passive Smoking on Platelet Function and Endothelial Function

Acute Effects of Short-term Exposure to Secondhand Smoke on Platelet Activation and Endothelial Function

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00923988
Enrollment
40
Registered
2009-06-18
Start date
2009-06-30
Completion date
2009-08-31
Last updated
2009-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endothelial Function, Platelet Aggregation

Keywords

Secondhand smoke, passive smoking, platelet function, endothelial function

Brief summary

Passive smoking is associated with an increased risk for cardiovascular events. However, the exact mechanisms by which passive smoking affects cardiovascular health are not entirely understood. In the present study, the researchers investigate the effects of short-term exposure to secondhand smoke on platelet function and peripheral microvascular endothelial function in healthy individuals. For this purpose, platelet function and endothelial function are measured before and after a 1-hour exposure to secondhand smoke in a concentration that is encountered in bars and restaurants without smoke-free policies. The researchers' hypothesis is that short-term exposure leads to platelet activation and impairment of endothelial function.

Interventions

OTHERsecondhand smoke exposure

Participants will be exposed to secondhand smoke for one hour. As a measure of secondhand smoke exposition, room carbon monoxide concentration will be continuously measured using an Ambient Carbon Monoxide Monitor APMA-360 and kept constant between 4.5-6.0 ppm. Levels in this magnitude are typically seen in smoking areas of restaurants and bars.

Sponsors

Kantonsspital Graubünden
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy individuals * nonsmokers * no regular medication (in particular no drugs affecting platelet function or vascular function)

Exclusion criteria

* exposition to secondhand smoke within 1 week before inclusion * use of drugs affecting platelet function or vascular function within 1 week before study inclusion

Design outcomes

Primary

MeasureTime frame
Change in platelet aggregation and/or endothelial function12-24 hours

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026